Biological E Limited partners with Bavarian Nordic to increase global access to Chikungunya Vaccine
This partnership comprises a technology transfer of the current drug product manufacturing process for the Chikungunya Vaccine, with the option to transfer the drug substance process at a later stage. Read further on Dynamite News:
Dynamite News ·